US Patent 7235658 Imidazol derivatives as Raf kinase inhibitors

Patent 7235658 was granted and assigned to Smithkline Beecham Limited on June, 2007 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

June 26, 2007

Patent Application Number

10220674

Date Filed

March 2, 2001

Patent Primary Examiner

Patent abstract

Compounds of formula (I):

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7235658 Imidazol derivatives as Raf kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.